Exclusivity Information
Iron Hydrogenated Dextran Injection Iron Dextran 20 Injection holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2027. Details of Iron Hydrogenated Dextran Injection Iron Dextran 20 Injection's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Jun 04, 2027 |
About Iron Hydrogenated Dextran Injection Iron Dextran 20 Injection
Iron Hydrogenated Dextran Injection Iron Dextran 20 Injection is a drug
owned by SPARHAWK LABORATORIES, INC.
Iron Hydrogenated Dextran Injection Iron Dextran 20 Injection uses
Iron Dextran Complex as the active
ingredient.
Active Ingredient:
Iron Hydrogenated Dextran Injection Iron Dextran 20 Injection uses
Iron Dextran Complex as the active ingredient.
Check out other Drugs and Companies using
Iron Dextran Complex ingredient.